Form D · Other
Tute Genomics, Inc.
Provo, UT · CIK 0001595296
Offering snapshot reported Nov 2, 2015 · SEC filing
- Reported sold
- $869K Offering amount: $919K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 27, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 2, 2015 | Initial | $868,532 | No comparison | 1 | SEC filing |
| Jul 16, 2015 | Amendment | $3,923,267 | $1,659,980vs Dec 5, 2014 | 15 | SEC filing |
| Dec 5, 2014 | Initial | $2,263,287 | No comparison | 10 | SEC filing |
| Dec 26, 2013 | Initial | $1,225,000 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-250479
Source: Form D, filed Nov 2, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeff Burningham | Director |
| Marina Nashif | Director |
| Dinesh Patel | Director |
| David Ristow | Director |
| Reid Robison | Director, Executive |
| Kai Wang | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
150 South 100 West
Provo, UT, 84601
Provo, UT, 84601